Earnings · China A-shares
Newland Pharmaceutical Co., Ltd. Class A (301277) earnings
Newland Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit -30.73% year on year, -34.18% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -4.61% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -30.73%
- Excl. one-offs YoY
- -34.18%
- Net profit QoQ
- -88.28%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -3.76% | — |
| 3 days | -4.61% | — |
| 7 days | -4.51% | — |
| 14 days | -8.58% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 3 of 8 reports (average -0.45%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥63.66M | -30.73% | -34.18% | +12.75% | 0.16 | 4.13% | -4.61% | — | — |
| 2026 interim report | 2026-08-28 | ¥60.77M | -22.13% | -23.78% | +10.64% | 0.15 | 3.91% | -0.57% | -3.92% | +5.77% |
| 2026 Q1 report | 2026-04-24 | ¥36.10M | -36.19% | -37.61% | -5.84% | 0.09 | 2.30% | +0.70% | -18.95% | -19.37% |
| 2025 annual report | 2026-03-20 | ¥121.25M | -30.17% | -32.40% | -7.44% | 0.31 | 7.93% | -6.18% | -4.95% | -11.33% |
| 2025 Q3 report | 2025-10-22 | ¥91.90M | -35.19% | -36.65% | -10.42% | 0.23 | 6.02% | -1.19% | -7.30% | -5.96% |
| 2025 interim report | 2025-08-12 | ¥78.03M | -30.01% | -31.56% | -9.57% | 0.20 | 5.06% | -7.97% | -16.25% | -26.05% |
| 2025 Q1 report | 2025-04-22 | ¥56.57M | +1.17% | +0.29% | +19.07% | 0.14 | 3.60% | +10.49% | +41.72% | +38.85% |
| 2024 annual report | 2025-03-11 | ¥173.63M | +9.22% | +11.40% | +11.51% | 0.44 | 11.72% | +5.73% | -21.87% | -16.75% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.